The present Invention relates to salts of 2 - [[4 - [5 - (2 - methyl - 1 - 2-naphthalenyl) - 1H pyrazole - 3 - il] oxy] ethyl] morpholine hydrochloride, specifically, to pharmaceutical compositions containing them and their use in therapy and / or prophylaxis Diseases associated with Sigma receptors.
展开▼